title: Clinical surveillance of gynecologic cancer patients.
abstract: A survey of gynecologic oncologists was used to determine the optimum follow-up plan for asymptomatic, disease-free patients previously treated for a gynecologic malignancy. Ninety-four (91%) of 103 questionnaires were completed and returned. The majority of respondents recommended a clinic visit for these patients every 3 months for the first year after the completion of therapy, every 3 or 4 months for the second year, every 6 months for the following 3 years, and then annually after this initial 5-year period. Breast, abdominal, lymph node, and pelvic examinations, as well as a pap smear and stool guaiac, were done at each of these clinic visits. A yearly chest X ray was performed by the majority of the survey respondents for the first 3 years following initial treatment. Determinations of serum CA-125 and ovarian germ cell tumor markers were done at each follow-up appointment during the first 5 years after therapy if they were previously elevated. The patients' smoking habits were discussed with them by the majority of respondents. Mammograms were performed periodically before age 50 and then yearly after age 50 by most respondents. Serum cholesterol determinations were accomplished every 5 years or more frequently if indicated. Calcium supplementation was recommended for postmenopausal patients. The majority of respondents did not recommend routine vitamin supplementation or surveillance sigmoidoscopy.
authors.affiliation: Department of Obstetrics and Gynecology, Walter Reed Army Medical Center, Washington, D.C. 20307.
authors.forename: D
authors.initials: D
authors.lastname: Barnhill
authors.forename: D
authors.initials: D
authors.lastname: O'Connor
authors.forename: J
authors.initials: J
authors.lastname: Farley
authors.forename: M
authors.initials: M
authors.lastname: Teneriello
authors.forename: D
authors.initials: D
authors.lastname: Armstrong
authors.forename: R
authors.initials: R
authors.lastname: Park
mesh_terms: D000553:Ambulatory Care; D002985:Clinical Protocols / Q000592:standards*; D005260:Female; D005500:Follow-Up Studies; D005833:Genital Neoplasms, Female / Q000628:therapy*; D006176:Gynecology / Q000592:standards*; D006801:Humans; D008495:Medical Oncology / Q000592:standards*; D011795:Surveys and Questionnaires; D013997:Time Factors